sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Jun-2015 08:45
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 1060.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 21-May-2015
Japanese Global Health Fund expands portfolio to include diagnostics and drugs for leishmaniasis
The Global Health Innovative Technology Fund (GHIT Fund), which in the last two years has funded almost $32 million for innovative tools to tackle global infectious diseases, today announced additional investments of nearly $11 million that bring its portfolio to approximately $43 million. GHIT Fund is expanding its technology scope to include diagnostic tests, its disease portfolio to include leishmaniasis, and its Screening Platform to include four additional Japanese companies and their unique chemical compound libraries.

Contact: Katy Lenard
klenard@burness.com
301-280-5719
Burness Communications

Public Release: 21-May-2015
PLOS Pathogens
Can a viral co-infection impair immunity against Plasmodium and turn malaria lethal?
It is known that infections with certain viruses can weaken the immune response to another pathogen. A study published on May 21 in PLOS Pathogens reports provocative findings in mice that infection with the mouse equivalent of Epstein-Barr virus can turn infections with certain parasites that cause malaria in mice (which are normally quickly suppressed by the immune system) into a lethal disease.

Contact: Samuel Speck
sspeck@emory.edu
404-727-7665
PLOS

Public Release: 20-May-2015
Journal of the American Heart Association
American College of Cardiology registry aims to improve cardiovascular care in India
Despite challenges, it is feasible to collect and study the quality of outpatient cardiovascular care in a resource-limited environment like India, according to a pilot study published today in the Journal of the American Heart Association. Researchers used the American College of Cardiology's PINNACLE India Quality Improvement Program registry to examine performance measures and outline areas for further improvement in cardiovascular care delivery.

Contact: Katie Glenn
kglenn@acc.org
202-375-6472
American College of Cardiology

Public Release: 20-May-2015
Proceedings of the National Academy of Sciences
UGA study pinpoints the likeliest rodent sources of future human infectious diseases
Researchers have developed a way to predict which species of rodents are likeliest to be sources of new disease outbreaks in humans. The findings could help public health officials take a more preemptive approach to disease surveillance, prevention and control.
National Institutes of Health

Contact: John Drake
jdrake@uga.edu
706-583-5539
University of Georgia

Public Release: 20-May-2015
Journal of Experimental Biology
New antibody insecticide targets malaria mosquito
Malaria is a cruel and disabling disease that targets all ages and is particularly threatening for under-5s. A team of scientists from Colorado State University, USA, is developing a new insecticide using a novel approach to target malaria mosquitoes. They use an animal's immune system to make an antibody that is consumed by the mosquito when it feeds. The antibody targets a key component of the insect's nervous system to paralyze and kill it.
National Institutes of Health, Colorado State University Infectious Disease Supercluster

Contact: Kathryn Knight
kathryn@biologists.com
44-012-234-25525
The Company of Biologists

Public Release: 19-May-2015
mBio
Study reveals intestinal bacteria succession during recovery from cholera in Bangladesh
A new study delineates a sequential pattern of changes in the intestinal microbial population of patients recovering from cholera in Bangladesh, findings that may point to ways of speeding recovery from the diarrheal disease. The report also finds consistent differences between the gut microbial population of individuals in countries like the US and those the developing world and provides some of the most complete evidence that the gut microbiota return to normal after cholera infection.
NIH/National Institute of Allergy and Infectious Diseases, International Center for Diarrhœal Disease Research

Contact: Noah Brown
nbrown9@partners.org
617-643-3907
Massachusetts General Hospital

Public Release: 19-May-2015
International Journal of Bioinformatics Research and Applications
Horizontal gene transfer in E. coli
Escherichia coli O104 is an emergent disease-causing bacterium various strains of which are becoming increasingly well known and troublesome. The pathogen causes bloody diarrhea as well as and potentially fatal kidney damage, hemolytic uremic syndrome. Infection is usually through inadvertent ingestion of contaminated and incompletely cooked food or other materials, such as animals feces.

Contact: Albert Ang
press@inderscience.com
Inderscience Publishers

Public Release: 19-May-2015
Unique Seattle partnership launches new water treatment product
Outdoor gear manufacturer Mountain Safety Research and international nonprofit PATH bring Community Chlorine Maker from idea to market.

Contact: Kate Davidson
kdavidson@path.org
206-302-4637
PATH

Public Release: 18-May-2015
Journal of Acquired Immune Deficiency Syndromes
Microclinics help keep Kenyan HIV patients in care
A team led by researchers from UC San Francisco, Organic Health Response, and Microclinic International is reporting results of a study that showed significant benefits of microclinics -- an innovative intervention that mobilized rural Kenyan HIV patients' informal social networks to support their staying in care.
Tides Foundation, Craigslist Foundation, Mulago Foundation, Rise Up Foundation, Horace W. Goldsmith Foundation, Segal Family Foundation, NIH/National Institutes of Allergy and Infectious Diseases, Doris Duke Charitable Foundation and others

Contact: Jeff Sheehy
jeff.sheehy@ucsf.edu
415-845-1132
University of California - San Francisco

Public Release: 18-May-2015
Proceedings of the National Academy of Sciences
Forecasting future infectious disease outbreaks
Machine learning can pinpoint rodent species that harbor diseases and geographic hotspots vulnerable to new parasites and pathogens. So reports a new study in the Proceedings of the National Academy of Sciences led by Barbara A. Han, a disease ecologist at the Cary Institute of Ecosystem Studies.
National Institutes of Health

Contact: Lori Quillen
quillenl@caryinstitute.org
845-677-7600 x121
Cary Institute of Ecosystem Studies

Public Release: 18-May-2015
Research4Life HINARI wins MLA's 2015 Darling Medal (Outstanding Health Science Collection)
The Medical Library Association and Research4Life partnership announced today that the HINARI program has received the MLA's 2015 Louise Darling Medal for Collection Development in the Health Sciences.

Contact: Natalia Rodriguez
communications@research4Life.org
Elsevier

Public Release: 18-May-2015
Journal of Acquired Immune Deficiency Syndromes
Microclinics help keep Kenyan HIV patients in care
The results showed that microclinics cut in half the normal rate of disengagement from care, which was defined as missing a clinic appointment by 90 days or more, when compared to the control group, and reduced the perceived stigma of HIV by 25 percent within the larger community.
Tides Foundation, Craigslist Foundation, Mulago Foundation, Rise Up Foundation, Horace W. Goldsmith Foundation, Segal Family Foundation, NIH/National Institute of Allergy and Infectious Diseases, Doris Duke Charitable Foundation and others

Contact: Jeff Sheehy
jeff.sheehy@ucsf.edu
415-845-1132
University of California - San Francisco

Public Release: 15-May-2015
60th Society of the Central American Cooperative Program for the Improvement of Crops and Animals
New mobile app extends outreach of SAWBO educational videos
Scientific Animations without Borders created an Android app, enabling outreach workers in developing countries to download and share animated educational videos about topics in health and agriculture.

Contact: Sharita Forrest
slforres@illinois.edu
217-244-1072
University of Illinois at Urbana-Champaign

Public Release: 14-May-2015
Emerging Infectious Diseases
Genomics laboratory capability in Liberia supports Ebola virus outbreak response
Army scientists working to support the Ebola virus outbreak response in West Africa have established the first genomic surveillance capability in Liberia, enabling them to monitor genetic changes in the virus within one week of sample collection. An article describing their work was recently published ahead of print in the online edition of Emerging Infectious Diseases.
Defense Threat Reduction Agency, Global Biosurveillance Technology Initiative, US Agency for International Development, Illumina

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 14-May-2015
American Journal of Transplantation
Study investigates the quality of organs from potential donors with HIV
In 2013, the United States government passed the HIV Organ Policy Equity (HOPE) Act, which allows research to be conducted on the safety of organ donation from deceased donors with HIV to recipients with HIV.

Contact: Evelyn Martinez
sciencenewsroom@wiley.com
Wiley

Public Release: 14-May-2015
Science
Anti-poverty strategy offers sustained benefit for ultra-poor, says study in Science
A new six-country study shows a comprehensive approach for the ultra-poor, the approximately one billion people who live on less than $1.25 a day, boosted livelihoods, income, and health. Published in Science, the research tested the effectiveness of an approach known as the 'Graduation model' in six countries by following 21,000 of the world's poorest people for three years. The data show this approach led to large and lasting impacts on their standard of living.

Contact: Jeff Mosenkis
jmosenkis@poverty-action.org
203-672-9552
Innovations for Poverty Action

Public Release: 14-May-2015
PLOS Pathogens
Bacteria contribute to immune suppression in skin after repeated schistosome exposure
Our two square meters of skin act as a defensive barrier against environmental pathogens but is also covered by beneficial commensal bacteria. A study published on May 14th in PLOS Pathogens explores this delicate balance and reports that when schistosome parasites repeatedly penetrate the skin they are cloaked in skin bacteria, leading to a tightly controlled and limited immune response, due in part to this cloaking mechanism.

Contact: Adrian Mountford
adrian.mountford@york.ac.uk
44-190-432-8595
PLOS

Public Release: 13-May-2015
Diabetes Technology & Therapeutics
Cybersecurity and the artificial pancreas -- what are the risks?
An artificial pancreas, designed for blood glucose control in diabetes, is controlled by software that runs on mobile computing platforms such as laptops, tablets, and smartphones, and operates over wireless networks under local or remote medical supervision.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 13-May-2015
Journal of Clinical Microbiology
New test could identify resistant tuberculosis faster
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
European Union's Seventh Framework Programme

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-203-108-3844
University College London

Public Release: 13-May-2015
TB Alliance launches 'Nix-TB' clinical trial to test new XDR-TB treatment
TB Alliance and its partners announced the start of a clinical trial of a new regimen to treat extensively drug-resistant tuberculosis. It is the first study to test an all-oral drug regimen, comprised of drugs with minimal pre-existing resistance, that has the potential to shorten, simplify, and improve treatment for XDR-TB.

Contact: Preeti Singh
psingh@burness.com
301-280-5722
Burness Communications

Public Release: 12-May-2015
Malaria Journal
Malaria testing yet to reach its potential
In a study published this month in Malaria Journal, researchers from Uppsala University and other institutions present a new model for systematically evaluating new malaria treatment programs in routine conditions across multiple countries.

Contact: Emily White Johansson
emily.johansson@kbh.uu.se
347-558-3981
Uppsala University

Public Release: 12-May-2015
HIV Medicine
Gender difference in vital cell count of HIV patients
Male HIV patients in rural South Africa reach the low immunity levels required to become eligible for antiretroviral treatment in less than half the time it takes for immunity levels to drop to similar levels in women, according to new research from the University of Southampton.

Contact: Steven Williams
s.williams@soton.ac.uk
44-238-059-2128
University of Southampton

Public Release: 12-May-2015
PLOS Medicine
Many fixed-dose drug combinations in India lack central regulatory approval
Fixed-dose drug combinations which have not received central regulatory approval are sold in substantial numbers in India -- despite concerns over the safety and efficacy of these combinations -- according to new research led by Queen Mary University of London and published in PLOS Medicine.

Contact: Charli Scouller
c.scouller@qmul.ac.uk
44-770-982-5741
Queen Mary, University of London

Public Release: 11-May-2015
Nature Medicine
Starved T cells allow hepatitis B to silently infect liver
Hepatitis B stimulates processes that deprive the body's immune cells of key nutrients that they need to function, finds new UCL-led research funded by the Medical Research Council and Wellcome Trust. The work helps to explain why the immune system cannot control hepatitis B virus infection once it becomes established in the liver, and offers a target for potential curative treatments down the line.
Medical Research Council, Wellcome Trust

Contact: Harry Dayantis
h.dayantis@ucl.ac.uk
44-203-108-3844
University College London

Public Release: 11-May-2015
PLOS Medicine
Global health leaders call for global biomedical R&D fund and mechanism
In advance of this month's World Health Assembly and the G7 summit in June, world leaders should consider the establishment of a global biomedical research and development fund and a mechanism to address the dearth in innovation for today's most pressing global health challenges, according to Bernard Pécoul, from the Drugs for Neglected Diseases Initiative, Geneva, Switzerland, and colleagues in an Essay published in this week's PLOS Medicine.

Contact: Hugh O' Brien
medicinepress@plos.org
PLOS

Showing releases 76-100 out of 1060.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>